Amgen earnings were $4.1B for the trailing 12 months ending Dec 31, 2024, with -39.3% growth year over year. The latest AMGN earnings report on Dec 31, 2024 announced Q4 2024 earnings of $627.0M, down 77.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AMGN reported annual earnings of $4.1B, with -39.1% growth.
AMGN past earnings growth
How has AMGN's earnings growth performed historically?
On AMGN's earnings call on Invalid Date, Amgen (NASDAQ: AMGN) reported Q4 2024 earnings per share (EPS) of $1.17, up 18.75% year over year. Total AMGN earnings for the quarter were $627.00 million. In the same quarter last year, Amgen's earnings per share (EPS) was $1.44.
As of the last Amgen earnings report, Amgen is currently profitable. Amgen's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $4.09 billion, a 39.11% decrease year over year.
What was AMGN's earnings growth in the past year?
As of Amgen's earnings date in Invalid Date, Amgen's earnings has grown -39.33% year over year. This is 407.91 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 368.58%. AMGN earnings in the past year totalled $4.09 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.